C5
7 drugs4
approved indications
7
Approved Drugs
6
Companies
12
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (12 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
ALEXION PHARM 2 drugs
SAMSUNG BIOEPIS CO LTD 1 drug
Amgen 1 drug
By Therapeutic Area
Other 7 drugs
By Therapeutic Area
Other 7 drugs
SOLIRIS, ULTOMIRIS, EPYSQLI, BKEMV +3 more
Indications Treated
CD55-deficient Protein-Losing EnteropathyCHAPLE DiseaseParoxysmal Nocturnal HemoglobinuriaAtypical Hemolytic Uremic SyndromeGeneralized Myasthenia GravisParoxysmal nocturnal hemoglobinuria (PNH)Atypical hemolytic uremic syndrome (aHUS)Generalized myasthenia gravis (gMG)Neuromyelitis optica spectrum disorder (NMOSD)Myasthenia GravisAnti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG)Anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD)